<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01338961</url>
  </required_header>
  <id_info>
    <org_study_id>HYPO-2010</org_study_id>
    <nct_id>NCT01338961</nct_id>
  </id_info>
  <brief_title>Normothermia Versus Hypothermia for Valvular Surgery Patients</brief_title>
  <official_title>Normothermia Versus Hypothermia for Patients With Valvular Heart Disease Operated Under Cardiopulmonary Bypass.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiopulmonary bypass (CPB) has been used successfully for cardiac surgery for over half a
      century. Hypothermia became a ubiquitous practice for adult patients undergoing CPB. To date,
      most studies have been conducted in coronary artery bypass graft (CABG) patients with
      conflicting results. Current evidence does not support one temperature management strategy
      for all patients. The purpose of this study is to compare the efficiency and safety of
      normothermic versus hypothermic CPB in valvular surgery patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac Troponin I release</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for Inotropic Support</measure>
    <time_frame>First 48 postoperative hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Perioperative Myocardial Infarction</measure>
    <time_frame>First 48 postoperative hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Type I and Type II neurological injury</measure>
    <time_frame>7 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Dialysis-dependent acute renal failure</measure>
    <time_frame>7 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of infectious complications</measure>
    <time_frame>30 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total units of Red Blood Cells transfused</measure>
    <time_frame>7 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit length of stay</measure>
    <time_frame>30 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>30 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of In-hospital mortality</measure>
    <time_frame>30 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NT-proBNP release</measure>
    <time_frame>First 24 postoperative hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding from chest tubes</measure>
    <time_frame>First 24 postoperative hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>Normothermic CPB</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard management. Patients will be kept at normothermia throughout the procedure (&gt;36oC).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypothermic CPB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be cooled to 31-32oC (nasopharyngeal) after the beginning of CPB. Rewarming will begin 10-15 min before release of aortic cross-clamp. The gradient between heat-exchanger and nasopharynx during rewarming will be maintained at 3oC. The rewarming will be stopped at 36,5oC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypothermic CPB</intervention_name>
    <description>Patients will be cooled to 31-32oC (nasopharyngeal) after the beginning of CPB. Rewarming will begin 10-15 min before release of aortic cross-clamp. The gradient between heat-exchanger and nasopharynx during rewarming will be maintained at 3oC. The rewarming will be stopped at 36,5oC</description>
    <arm_group_label>Hypothermic CPB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Isolated heart valve surgery

          -  Heart valve surgery plus CABG

          -  Age 20-80

        Exclusion Criteria:

          -  urgent operation

          -  Left ventricle ejection fraction &lt; 35%

          -  Decompensated congestive heart failure

          -  Chronic renal failure (glomerular filtration rate &lt; 60 ml/min)

          -  Severe hepatic and pulmonary disease

          -  Bleeding diathesis or history of coagulopathy

          -  Planed deep hypothermic circulatory arrest

          -  History of acute myocardial infarction in the last 3 month

          -  Preoperative core temperature &gt;37oC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vladimir V Lomivorotov, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Institute of Pathology of Circulation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>State Research Institute of Circulation Patholody</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <results_reference>
    <citation>Lomivorotov VV, Shmirev VA, Efremov SM, Ponomarev DN, Moroz GB, Shahin DG, Kornilov IA, Shilova AN, Lomivorotov VN, Karaskov AM. Hypothermic versus normothermic cardiopulmonary bypass in patients with valvular heart disease. J Cardiothorac Vasc Anesth. 2014 Apr;28(2):295-300. doi: 10.1053/j.jvca.2013.03.009. Epub 2013 Aug 17.</citation>
    <PMID>23962460</PMID>
  </results_reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2011</study_first_submitted>
  <study_first_submitted_qc>April 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2011</study_first_posted>
  <last_update_submitted>October 30, 2013</last_update_submitted>
  <last_update_submitted_qc>October 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meshalkin Research Institute of Pathology of Circulation</investigator_affiliation>
    <investigator_full_name>Efremov Sergey</investigator_full_name>
    <investigator_title>Anesthesist</investigator_title>
  </responsible_party>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Normothermia</keyword>
  <keyword>Troponin I</keyword>
  <keyword>Bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

